[an error occurred while processing this directive]

Advanced Ultrasound in Diagnosis and Therapy ›› 2018, Vol. 2 ›› Issue (1): 1-7.doi: 10.37015/AUDT.2018.180004

• • 上一篇    下一篇

  

  • 收稿日期:2018-01-07 修回日期:2018-01-21 出版日期:2018-03-30 发布日期:2018-07-23

Safety and Efficacy of Percutaneous Radiofrequency Ablation Combined with Percutaneous Ethanol Injection for Hepatocellular Carcinoma in High-risk Locations

Meng Li, MDa, Zhiyan Li, MDa,*(), Yuejuan Gao, MDa, Jiangke Tian, MDa, Min Chen, MDa, Jinghui Dong, MDb   

  1. aDepartment of Ultrasound, Beijing 302 Hospital, Beijing, China
    bDepartment of Radiology, Beijing 302 Hospital, Beijing, China
  • Received:2018-01-07 Revised:2018-01-21 Online:2018-03-30 Published:2018-07-23
  • Contact: Zhiyan Li, MD E-mail:lzyyuer@sina.com

RichHTML

5

PDF (PC)

359

Abstract:

Objective: The purpose of the study was to evaluate the safety and efficacy of percutaneous ultrasound (US) guided radiofrequency ablation combined with percutaneous ethanol injection to treat hepatocellular carcinoma in presumably high-risk locations.
Methods: Between September 2013 to December 2016, A total of 69 hepatocellular carcinoma patients with 76 nodules in high-risk locations, defined as less than 0.5cm from a large vessel or an extrahepatic organ, who underwent US-guided percutaneous radiofrequency ablation, combined with percutaneous ethanol injection, were retrospectively assessed. One or two radiofrequency electrodes were inserted and placed at designated places in the tumor. One ethanol needle was placed at the tumor periphery near the high-risk location. Absolute ethanol was injected into the tumor before radiofrequency ablation.. The safety and efficacy of the therapy were assessed by clinical data and imaging in follow-up examinations.
Results: All tumors were completely treated with one or two sessions; 61 tumors underwent one session; 15 tumors underwent two sessions. The primary technique was effective in 73 (96.1%) tumors, according to computed tomography (CT) or magnetic resonance imaging (MRI) follow up. No patients had major complications. Two (2.9%) patients died of primary disease progression that was not directly attributable to radiofrequency ablation. Local tumor progression was noted in 3 (3.9%) tumors in the follow-up period. The locally progressing tumors underwent additional therapy (one patient underwent radiofrequency ablation and transcatheter arterial chemoembolization, another patient with 2 nodules underwent transcatheter arterial chemoembolization).
Conclusions: US-guided percutaneous radiofrequency ablation, in combination with percutaneous ethanol injection, is a safe and effective treatment for hepatocellular carcinoma in high-risk locations.

Key words: Ultrasound, Radiofrequency ablation, Hepatocellular carcinoma

[1] El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127.
[2] Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015 Jul; 1:505-27.
[3] de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol 2012; 56 Suppl 1:S75-87.
[4] Nishikawa H, Kimura T, Kita R, Osaki Y. Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia 2013 Sep; 29:558-568.
[5] Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012 Mar 31; 379:1245-1255.
[6] Dhir M, Melin AA, Douaiher J, Lin C, Zhen WK, Hussain SM, et al. A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma. Ann Surg 2016 Jun; 263:1112-1125.
[7] Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology 2011; 53:1020-1022.
[8] Hocquelet A, Balageas P, Laurent C, Blanc JF, Frulio N, Salut C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia 2015; 31:749-757.
[9] Chapiro J, Geschwind JF. Percutaneous therapies of hepatocellular carcinoma-an update. Chin Clin Oncol 2013; 2:36.
[10] Li M, Li Z, Yu X, Liang P, Gao Y, Han Z, et al. Percutaneous radio-frequency ablation of hepatocellular carcinoma adjacent to the gastrointestinal tract. Int J Hyperthermia 2016 Sep; 32:600-606.
[11] Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006 May; 43:1101-1108.
[12] Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005 Jul; 129:122-130.
[13] Huang J, Li T, Liu N, Chen M, He Z, Ma K, et al. Safety and reliability of hepatic radiofrequency ablation near the inferior vena cava: an experimental study. Int J Hyperthermia 2011; 27:116-123.
[14] Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004 Dec; 127:1714-1723.
[15] Haemmerich D, Laeseke PF. Thermal tumor ablation: devices, clinical applications and future directions. Int J Hyperthermia 2005; 21:755-760.
[16] Cammà C, Di Marco V, Orlando A, Sandonato L, Casaril A, Parisi P, et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 2005 Apr; 42:535-540.
[17] Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005 Aug; 242:158-171.
[18] Poch FG, Rieder C, Ballhausen H, Knappe V, Ritz JP, Gemeinhardt O, et al. The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo. Int J Hyperthermia 2016 Nov; 32:749-756.
[19] Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003 Feb; 226:441-451.
[20] Meloni MF, Goldberg SN, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 2002 Jun; 15:73-76.
[21] Hocquelet A, Balageas P, Frulio N, Trillaud H. Aggressive Intrasegmental Recurrence of Periportal Hepatocellular Carcinoma after Radiofrequency Ablation: Role of Ablative Technique and Heat-Sink Effect? Radiology 2015 Sep; 276:932-933.
[22] Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scand J Gastroenterol 2008; 43:727-735.
[23] Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991 Oct 1; 68:1524-1530.
[24] Kwon JH. Is percutaneous ethanol injection therapy still effective for hepatocellular carcinoma in the era of radiofrequency ablation? Gut Liver 2010; 4 Suppl 1: S105-112.
[25] Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, et al. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw 2017 May; 15:563-573.
[26] Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. International Working Group on Image-guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology, Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumor ablation: standardization of terminology and reporting criteria a 10-year update. Radiology 2014 Oct; 273:241-260.
[27] Meloni MF, Goldberg SN, Moser V, Piazza G, Livraghi T. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 2002 Jun; 15:73-76.
[28] Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98:1210-1224.
[29] Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003 Feb; 226:441-451.
[30] Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005 Mar 15; 103:1201-1209.
[31] Chen MH, Yang W, Yan K, Hou YB, Dai Y, Gao W, et al. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach. Abdom Imaging 2008 Jul-Aug; 33:428-436.
[32] Hasegawa T, Takaki H, Miyagi H, Nakatsuka A, Uraki J, Yamanaka T, et al. Hyaluronic acid gel injection to prevent thermal injury of adjacent gastrointestinal tract during percutaneous liver radiofrequency ablation. Cardiovasc Intervent Radiol 2013 Aug; 36:1144-1146.
[33] Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 2009 Nov; 19:2630-2640.
[34] Zhang M, Liang P, Cheng ZG, Yu XL, Han ZY, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia 2014 Mar; 30:134-141.
[35] Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol 2008 Mar; 190:W187-195.
[36] Zhou P, Liu X, Li R, Nie W. Percutaneous coagulation therapy of hepatocellular carcinoma by combining microwave coagulation therapy and ethanol injection. Eur J Radiol 2009 Aug; 71:338-342.
[37] Vallone P, Catalano O, Izzo F, Siani A. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 2006 Jul-Aug; 29:544-551.
[38] Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004 Dec; 127:1714-1723.
No related articles found!
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
[an error occurred while processing this directive]